| Literature DB >> 35477817 |
Fatma Dilsad Oz1, Canan Ozturk2, Reza Soleimani3, Sevil Gurgan4.
Abstract
OBJECTIVE: The purpose of this clinical trial was to evaluate and compare the performances of three different universal adhesives used with a highly filled flowable universal resin composite in the restoration of non-carious cervical lesions (NCCLs) over a 60-month period.Entities:
Keywords: Non-carious cervical lesion; Selective enamel etching; Universal adhesive
Mesh:
Substances:
Year: 2022 PMID: 35477817 PMCID: PMC9045793 DOI: 10.1007/s00784-022-04505-x
Source DB: PubMed Journal: Clin Oral Investig ISSN: 1432-6981 Impact factor: 3.606
Inclusion and exclusion criteria for participants
| Inclusion criteria | Exclusion criteria |
|---|---|
(a) Being at least 18 years old (b) Having at least 20 teeth under occlusion (c) Having at least three NCCLs that needed restoration in different teeth and that were similar in size (depth), ranging from 1 to 3 mm | (a) Severe periodontal disease; rampant, uncontrolled caries; xerostomia (b) Serious medical problems preventing them from attending review visits (c) Poor gingival health (d) Heavy bruxism (e) Removable partial dentures (f) Undergoing bleaching treatment or orthodontic treatment (g) Patients with severe hypersensitivity (checked with a cold test) |
Materials used in the study
| Material/manufacturer | Batch No | Composition | Application |
|---|---|---|---|
| Clearfil Universal Bond/Kuraray Dental, Tokyo, Japan | 4T0015 | MDP Bis-GMA HEMA Hydrophilic aliphatic dimethacrylate Colloidal silica Silane coupling agent dl-Camphorquinone Ethanol Water | Apply phosphoric acid etching gel (37%) to the enamel, leave it in place for 30 s, and then rinse and dry Apply bond to the entire lesion with the applicator brush and rub for 10 s Dry the entire lesion sufficiently by blowing mild air for more than 5 s until bond does not move Light-cure bond with 1200 mW/cm2 LED for 10 s |
| iBOND Universal/Heraeus Kulzer, Hanau, Germany | 010021 | Acetone 4-methacryoxyethltrimellitic acid anhydride Diurethane dimethacrylate | Apply phosphoric acid etching gel (37%) to enamel and leave it in place for 30 s, and then rinse and dry Apply bond to the entire lesion with the applicator brush and rub for 20 s Dry the entire lesion sufficiently by blowing mild air for more than 5 s until bond does not move Light-cure bond with 1200 mW/cm2 LED for 10 s |
| G-Premio Bond/GC, Tokyo, Japan | 160413A | MDP Acetone Dimethacrylate Phosphoric acid ester monomer Photoinitiator BHT MDTP | Apply phosphoric acid etching gel (37%) to enamel and leave it in place for 30 s and then rinse and dry Apply bond to the lesion with the applicator brush Leave undisturbed for 10 s Dry thoroughly for 5 s under maximum air pressure Light-cure bond with 1200 mW/cm2 LED for 10 s |
| G-ænial Universal Flo/GC, Tokyo, Japan | 1208012 | UDMA Bis-MEPP TEGDMA Silicon dioxide (16 nm) Strontium glass (200 nm) Pigment Photo initiator | Place the dispensing tip as close as possible to the lesion and slowly push the plunger to syringe material Light-cure for 20 s (LED) (1200 mW/cm2) |
UDMA, urethane dimethacrylate; MDP, 10-methacryloyloxydecyl dihydrogen phosphate; Bis-GMA, bisphenol A diglycidyl methacrylate; HEMA, 2-hydroxyethyl methacrylate; BHT, butylated hydroxytoluene; MDTP, methacryloyloxydecyl dihydrogen thiophosphate
Fig. 1Flow diagram of the study. nP, number of patients; nR, number of restorations; CU, Clearfil Universal Bond; IU, iBOND Universal; GP, G-Premio Bond
Clinical evaluation outcomes of different adhesive systems
| Evaluation criteria | Score | Baseline | 6 months | 12 months | 18 months | 24 months | 36 months | 60 months | ||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| CU ( | IU ( | GP ( | CU ( | IU ( | GP ( | CU ( | IU ( | GP ( | CU ( | IU ( | GP ( | CU ( | IU ( | GP ( | CU ( | IU ( | GP ( | CU ( | IU ( | GP ( | ||
| Retention | Alpha | 31 (100) | 33 (100) | 35 (100) | 31 (100) | 33 (100) | 35 (100) | 31 (100) | 33 (100) | 35 (100) | 29 (100) | 30 (96.8) | 33 (100) | 29 (100) | 30 (100) | 33 (100) | 22 (91.7) | 26 (96.3) | 30 (100) | 20 (95.2) | 23 (92.0) | 28 (96.6) |
| Bravo | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | |
| Charlie | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 1 (3.2) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 2 (8.3) | 1 (3.7) | 0 (0) | 1 (4.8) | 2 (8.0) | 1 (3.4) | |
| Marginal adaptation | Alpha | 31 (100) | 33 (100) | 35 (100) | 31 (100) | 33 (100) | 33 (94.3) | 29 (93.5) | 30 (90.9) | 30 s (85.7) | 27 (93.1) | 27 (90.0) | 27 s (81.8) | 26 (89.7) | 24 (80.0) | 26 (78.8) | 18 (81.8) | 18 (69.2) | 20 (66.7) | 15 (75.0) | 15 (65.2) | 16 (57.1) |
| Bravo | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 2 (5.7) | 2 (6.5) | 3 (9.1) | 5 s (14.3) | 2 (6.9) | 3 (10.0) | 6 s (18.2) | 3 (10.3) | 6 s (20.0) | 7 s (21.2) | 4 (18.2) | 8 s (30.8) | 10 s (33.3) | 5 (25.0) | 8 s (34.8) | 12 s (42.9) | |
| Charlie | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | |
| Marginal discoloration | Alpha | 31 (100) | 33 (100) | 35 (100) | 31 (100) | 33 (100) | 34 (97.1) | 31 (100) | 30 (90.9) | 32 (91.4) | 29 (100) | 27 (90.0) | 29 (87.9) | 29 (100) | 27 (90.0) | 29 (87.9) | 22 (100) | 20 (76.9) | 24 (80) | 20 (100) | 17 (73.9) | 19 (67.9) |
| Bravo | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 1 (2.9) | 0 (0) | 3 (9.1) | 3 (8.6) | 0 (0) | 3 (10.0) | 4 (12.1) | 0 (0) | 3 (10.0) | 4 (12.1) | 0 (0) | 6 s (23.1) | 6 s (20.0) | 0 (0) | 6 s (26.1) | 9 s (32.1) | |
| Charlie | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | |
| Surface texture | Alpha | 31 (100) | 33 (100) | 35 (100) | 29 (93.5) | 33 (100) | 35 (100) | 29 (93.5) | 30 (90.9) | 30 (85.7) | 27 (93.1) | 27 (90.0) | 28 (84.8) | 27 (93.1) | 25 (83.3) | 27 (81.8) | 20 (90.9) | 21 (80.8) | 24 (80.0) | 18 (90.0) | 16 (69.6) | 22 (78.6) |
| Bravo | 0 (0) | 0 (0) | 0 (0) | 2 (6.5) | 0 (0) | 0 (0) | 2 (6.5) | 3 (9.1) | 5 s (14.3) | 2 (6.9) | 3 (10.0) | 5 s (15.2) | 2 (6.9) | 5 s (16.7) | 6 s (18.2) | 2 (9.1) | 5 s (19.1) | 6 s (20.0) | 2 (10) | 7 s (30.4) | 6 s (21.4) | |
| Charlie | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | |
| Color match | Alpha | 31 (100) | 33 (100) | 35 (100) | 29 (93.5) | 33 (100) | 35 (100) | 29 (93.5) | 33 (100) | 34 (97.1) | 27 (93.1) | 30 (100) | 32 (97) | 27 (93.1) | 30 (100) | 32 (97.0) | 20 (90.9) | 26 0 (0) | 29 (96.7) | 18 (90.0) | 23 (100) | 27 (96.4) |
| Bravo | 0 (0) | 0 (0) | 0 (0) | 2 (6.5) | 0 (0) | 0 (0) | 2 (6.5) | 0 (0) | 1 (2.9) | 2 (6.9) | 0 (0) | 1 (3) | 2 (6.9) | 0 (0) | 1 (3.0) | 2 (9.1) | 0 | 1 (3.3) | 2 (10.0) | 0 (0) | 1 (3.6) | |
| Charlie | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | |
| Post-operative sensitivity | Alpha | 31 (100) | 33 (100) | 35 (100) | 31 (100) | 33 (100) | 35 (100) | 31 (100) | 33 (100) | 35 (100) | 29 (100) | 30 (100) | 33 (100) | 29 (100) | 30 (100) | 33 (100) | 22 (100) | 26 (100) | 30 (100) | 20 (100) | 23 (100) | 28 (100) |
| Bravo | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | |
| Charlie | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | |
| Secondary caries | Alpha | 31 (100) | 33 (100) | 35 (100) | 31 (100) | 33 (100) | 35 (100) | 31 (100) | 33 (100) | 35 (100) | 29 (100) | 30 (100) | 33 (100) | 29 (100) | 30 (100) | 33 (100) | 22 (100) | 26 (100) | 30 (100) | 20 (100) | 23 (100) | 28 (100) |
| Bravo | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | |
| Charlie | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | |
USPHS, US Public Health Service
sIndicates significant difference in comparison with baseline according to Cochran’s Q test fallowed by McNemar’s test (p < 0.05)
CU, Clearfil Universal Bond; IU, iBOND Universal; GP, G-Premio Bond
Fig. 2Survival curves for the tested groups (CU [Clearlfil Universal Bond], IU [iBOND Universal], GP [G-Premio Bond])